Komen vice president resigns

NewsGuard 100/100 Score

Karen Handel says she is leaving immediately so the organization can "refocus" on its mission, after becoming a lightning rod for controversy over its decision to cut funds to Planned Parenthood.

Los Angeles Times: Komen Executive Quits As Questions Persist
The Susan G. Komen for the Cure foundation took another step toward rehabilitating its standing in the breast cancer community with the resignation of the executive at the center of the Planned Parenthood funding controversy. In a largely conciliatory letter, Karen Handel, senior vice president for public policy, said Tuesday that she would step down immediately so the organization could "refocus its attention and energies on its mission" (Roan and Brown, 2/7).

NPR: Controversial Komen Policy Official Resigns
A high-ranking official at the Susan G. Komen for the Cure foundation has resigned amid fallout from the charity's move, since reversed, to halt funding for breast cancer screening by Planned Parenthood. Karen Handel, a former Republican candidate for governor in Georgia, resigned her job, effective immediately, as senior vice president for public policy (Hensley, 2/7).

The Atlanta Journal-Constitution: Handel Resigns From Komen; Cites 'Vicious Attack' From Planned Parenthood
Karen Handel accused the Planned Parenthood Federation of America Tuesday of plotting for a month before launching an orchestrated "shakedown" of Susan G. Komen for the Cure. Handel, who resigned Tuesday as Komen's vice president of public policy, said Planned Parenthood was informed in December that Komen had revised its grant-making policies, making Planned Parenthood ineligible for future grants. She said Komen was "blind-sided" last week when the media suddenly got hold of the story, precipitating a public relations debacle that, she said, Komen was ill-equipped to handle…. Planned Parenthood rejected Handel's accusations (Leslie, 2/7).

Bloomberg: Komen Foundation Official Resigns After Funding Feud With Planned Parenthood
Karen Handel, a senior vice president of public policy for Susan G. Komen for the Cure, resigned after the breast-cancer group decided to overturn a decision to end grants to Planned Parenthood Federation of America. Handel, who ran unsuccessfully for governor in Georgia in 2010, today criticized Planned Parenthood for its "guerilla tactics," saying "for an outside organization to come in like they did and conduct this shakedown is outrageous." The Komen organization's decision to end about $680,000 in grants drew thousands of online protests and complaints and helped Planned Parenthood raise $3 million in reaction (Lopatto and Newkirk, 2/7).

NPR's SHOTS blog: Controversy Over Stem-Cell Research Keeps Charities On Sidelines
Despite raising millions of dollars for breast cancer research, Komen hasn't funded any [embryonic stem-cell research], prompting questions about whether that decision is rooted in politics. ... Many scientists think human embryonic stem cells could lead to cures for many ailments, including heart disease, diabetes, some forms of blindness and possibly cancer. But human embryos have been destroyed to obtain some of the cells. ... Komen isn't alone. Neither the American Cancer Society nor the American Heart Association funds research with human embryonic stem cells (Stein, 2/7). 

Meanwhile, Planned Parenthood says the controversy raised awareness about the work it does. But anti-abortion groups continue to fight the group.

McClatchy / The Charlotte Observer: Planned Parenthood President Says Komen Controversy Has Had Benefits
Speaking in Charlotte on Tuesday, the national president of Planned Parenthood said last week's angry reaction to a funding cut by the Susan G. Komen foundation not only benefited Planned Parenthood financially but raised awareness of its mission. … Cecile Richards headlined a fundraiser for the Planned Parenthood Action Fund at the Levine Museum of the New South. Her appearance came on the same day that a Komen official blamed for the controversy resigned (Morrill, 2/8).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New trials show promise for immune checkpoint blockers in early-stage lung cancer